²´²\¥iÅç¬fª÷»¹¡H
¡i©ú³ø±M°T¡j²´²\¤£¥u¦³¤ô¤À¡AÁÙ§t¦³²\¸¢¦]À³¯«¸g¨t²Î«H¸¹¦Ó¤Àªcªº¦hºØ³J¥Õ½è¡C¼vÅT¯«¸g¨t²Îªº¬fª÷»¹¯f·|¥O²´²\¤¤ªº§C»Eªüº¸ªk¡X¡X¬ðIJ®Ö³J¥Õ(oligomeric alpha-synuclein)¤ô¥´£°ª5¿¡C¬ü°ê«n¥[¦{¤j¾Ç¯«¸g¬ì¾Ç®a°¨§J¿c(Mark Lew)»{¬°¥i³q¹L³o¯SÂIÀË´ú¤H̬O§_±w¦³¬fª÷»¹¯f©O¡I
(2)¬fª÷»¹¯f¦³¦ó¯f¼x¡H
A. ¨«¸ô©ö¥¢¥¿Å
B. ¤â¸}¾_Ÿ
C. ¤â¸}¦Ù¦×»øµw
D. ¥H¤W¬Ò¬O
¡½ÃöÁäµü
¬fª÷»¹¯f Parkinson's Disease
³J¥Õ½è protein
[±`ÃѤѤU ²Ä113´Á]